# Patient Care Plan

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Elizabeth Barrett Browning (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-NI026-SYN
- Date: 2026-03-16
- Fictional facility: St. Posthumous Health Center
- Fictional author: Clementine Haverford-Asante, MD
- Calendar frame: modern shifted

## What we are working on

- She has coughed for years and lately sees streaks of blood; she wants to know whether it is consumption **S**
- She worries that the morphine she has taken for so long is harming her, but fears being made to stop it **S**
- She wants to keep writing, and to be able to think of her brother without being overwhelmed **S**

## Your goals

- Tuberculosis excluded and a diagnosis for the cough within two weeks. Target: 2026-03-23. Recorded outcome: Smears, NAAT and IGRA negative within a week; bronchiectasis diagnosed by CT at one week. **S**
- Airway clearance twice daily, with less sputum and no blood in it, by three months. Target: 2026-06-15. Recorded outcome: Airway clearance twice daily; sputum down from about four to one tablespoon a day; no blood since the first month. **S**
- Safe opioid therapy: naloxone at home, no overdose or sedation, and any dose change only by her choice. Target: 2026-10-19. Recorded outcome: Naloxone at home; no sedation; she chose to reduce from 20 to 14 mg a day over seven months without troublesome withdrawal. **S**
- Response of grief and depressive symptoms (PHQ-9 down by at least half) by six months. Target: 2026-10-19. Recorded outcome: PHQ-9 5 from 12 after sixteen sessions of grief therapy; she can speak of her brother. **S**
- Weight up toward a BMI of 18.5 (45.6 kg) by seven months. Target: 2026-10-19. Recorded outcome: 44.2 kg from 41.5 kg (BMI 17.9); still gaining. **S**
- Vitamin D above 30 ng/mL by twelve weeks. Target: 2026-06-15. Recorded outcome: 34 ng/mL. **S**

## What we agreed to do

- Evaluation of chronic cough with blood-streaked sputum: three sputum samples at least eight hours apart, one early morning, for acid-fast smear, nucleic acid amplification and mycobacterial culture (including nontuberculous mycobacteria) and routine bacterial culture; interferon-gamma release assay and HIV test; blood count, CRP and metabolic panel; CT of the chest within a week; a mask in shared spaces until the smears are negative; call 911 or go to the emergency department for more than a few teaspoons of blood, blood with breathlessness, or chest pain. Guideline: British Thoracic Society Guideline for Bronchiectasis in Adults (2019); Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children (2017); Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline (2020) **S**
- Urgent pulmonology consultation within one week for chronic productive cough with blood-streaked sputum: exclude tuberculosis, confirm or exclude bronchiectasis and plan its care, and advise on opioids and the lungs. Guideline: British Thoracic Society Guideline for Bronchiectasis in Adults (2019); Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children (2017) **S**
- Long-term opioid therapy review: prescription monitoring program checked (one prescriber, one pharmacy), urine drug test consistent with morphine only, naloxone prescribed and taught, no benzodiazepines or other sedatives, DSM-5-TR assessment (no opioid use disorder), dose continued unchanged with no forced taper, benefits and harms reviewed at every visit and at least every three months, the monitoring program checked with every prescription, and buprenorphine offered if opioid use disorder ever develops. Guideline: CDC Clinical Practice Guideline for Prescribing Opioids for Pain, United States, 2022 (2022); Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR): opioid use disorder and prolonged grief disorder criteria (2022) **S**
- Prolonged grief disorder therapy with the clinic psychologist, weekly for sixteen sessions, by video at first so she need not travel; PHQ-9 at every visit. Guideline: Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR): opioid use disorder and prolonged grief disorder criteria (2022); Shear MK, et al. Optimizing Treatment of Complicated Grief: A Randomized Clinical Trial (2016); CMID: Clinical Monitoring Intelligence Database, depression and osteoporosis monographs (2026) **S**
- Collaborative safety plan with warning signs, coping steps, people to contact, the clinic number and the 988 Suicide & Crisis Lifeline; morphine kept in a locked box with only the current bottle out; safety reviewed at every visit. Guideline: CDC Clinical Practice Guideline for Prescribing Opioids for Pain, United States, 2022 (2022); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024) **S**
- Bone and nutrition: vitamin D3 2000 units daily with a recheck at twelve weeks; DXA for low weight, vitamin D deficiency, limited weight-bearing and long-term opioid therapy; calcium-rich foods, small frequent meals and an oral supplement drink with the clinic dietitian; weight at every visit. Guideline: CMID: Clinical Monitoring Intelligence Database, depression and osteoporosis monographs (2026) **S**
- Bronchiectasis care: active cycle of breathing with an oscillating positive expiratory pressure device twice daily, taught by the respiratory physiotherapist; a home exercise program; influenza, pneumococcal and COVID-19 vaccines; a written exacerbation plan with a sputum sample and amoxicillin 500 mg three times daily for 14 days; sputum culture at each review and spirometry, Bronchiectasis Severity Index and mycobacterial culture yearly; no long-term macrolide while exacerbations are fewer than three a year. Guideline: British Thoracic Society Guideline for Bronchiectasis in Adults (2019); European Respiratory Society guidelines for the management of adult bronchiectasis (2017) **S**
- Opioid dose reduction at her request: morphine lowered by about 10 percent at a time (to 18 mg a day now), with each step held at least four weeks, paused at any time she wishes, and never forced; withdrawal symptoms and sleep reviewed at each visit. Guideline: CDC Clinical Practice Guideline for Prescribing Opioids for Pain, United States, 2022 (2022) **S**
- Exacerbation of bronchiectasis: sputum culture before the first dose; amoxicillin 500 mg three times daily for 14 days; airway clearance three to four times a day; fluids; the morphine dose unchanged and no added cough suppressant; nurse phone check in two days; call 911 for more than a few teaspoons of blood, worsening breathlessness or confusion. Guideline: British Thoracic Society Guideline for Bronchiectasis in Adults (2019); CDC Clinical Practice Guideline for Prescribing Opioids for Pain, United States, 2022 (2022) **S**

## Follow-up

- 2026-03-16: New patient visit for chronic cough with blood-streaked sputum, a long-term opioid prescription, and grief, with tuberculosis testing and urgent pulmonology referral **S**
- 2026-03-23: Pulmonology consultation with CT of the chest and spirometry, diagnosis of bronchiectasis, and the start of airway clearance **S**
- 2026-04-20: Four-week review: mycobacterial cultures, airway clearance, bone density, grief therapy, and her choice about the opioid dose **S**
- 2026-06-15: Three-month review: final mycobacterial cultures, vitamin D, mood, safety, and the opioid dose **S**
- 2026-07-13: Periodic adult preventive visit **S**
- 2026-10-19: Seven-month review after an exacerbation: lungs, opioid therapy, mood, safety, weight, and vaccines **S**

This teaching document does not replace care from a qualified clinician.
